MF
ETON icon

Magnetar Financial’s Eton Pharmaceutcials ETON Stock Holding History

Magnetar Financial’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,731
Closed -$196K – 981
2025
Q2 		$196K Buy
+13,731
New +$217K ﹤0.01% 803

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Magnetar Financial's ETON Position: Q3 2025 in Review

Magnetar Financial sold out of Eton Pharmaceutcials (ETON) in Q3 2025, closing a stake of 13,731 shares — an estimated $196K sold.

Magnetar Financial first reported a position in ETON in Q2 2025 and held it in 1 quarter. The position peaked at $196K in Q2 2025. 103 funds tracked by Wall St. Rank hold ETON as of Q3 2025.

  • Magnetar Financial reported no remaining Eton Pharmaceutcials position as of Q3 2025 after selling out during the quarter.
  • Magnetar Financial sold 13,731 Eton Pharmaceutcials shares in Q3 2025, an estimated $196K.
  • Magnetar Financial first reported a position in Eton Pharmaceutcials in Q2 2025 and held it in 1 quarter.
  • Magnetar Financial's Eton Pharmaceutcials position peaked at $196K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2025.

Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.